IL1B and metabolic syndrome: Low-grade chronic inflammation, with excess fat driving the release of proinflammatory cytokines such as TNF and IL-1β  46, is associated with adiposity, insulin resistance, hyperleptinemia, metabolic syndrome and type 2 diabetes 47–51.